A Fluoresceina, Colircusi CEP of the European Pharmacopoeia monograph is often referred to as a Fluoresceina, Colircusi Certificate of Suitability (COS). The purpose of a Fluoresceina, Colircusi CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fluoresceina, Colircusi EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fluoresceina, Colircusi to their clients by showing that a Fluoresceina, Colircusi CEP has been issued for it. The manufacturer submits a Fluoresceina, Colircusi CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fluoresceina, Colircusi CEP holder for the record. Additionally, the data presented in the Fluoresceina, Colircusi CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fluoresceina, Colircusi DMF.
A Fluoresceina, Colircusi CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fluoresceina, Colircusi CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fluoresceina, Colircusi suppliers with CEP (COS) on PharmaCompass.